Marico Q1 FY26 revenue rose 23%; resurfacing August move to raise Plix owner stake to 60%
Marico had posted Q1 FY26 consolidated revenue of Rs 3,259 crore, up 23.3% year on year, while net profit rose 8.2% to Rs 513 crore. India revenue grew 27.2% and international revenue 12.9%. The FMCG company also raised its fully diluted stake in Satiya Nutraceuticals, owner of Plix, to 60%, a move first reported in early August 2025.
What happened
Marico reported Q1 FY26 profit growth of 8.2% and revenue growth of 23.3%, led by 27.2% India revenue growth. It raised its Plix owner Satiya Nutraceuticals
Key facts
- Q1 FY26 consolidated net profit: Rs 513 crore, up 8.2% YoY from Rs 474 crore
- Revenue from operations: Rs 3,259 crore, up 23.31% YoY from Rs 2,643 crore
- Total income: Rs 3,315 crore, including Rs 56 crore other income
- India revenue: Rs 2,495 crore, up 27.17% YoY from Rs 1,962 crore
- International revenue: Rs 764 crore, up 12.91% YoY from Rs 681 crore
- India profit before tax: Rs 469 crore
- International profit before tax: Rs 213 crore
- Total expenses: Rs 2,659 crore, versus Rs 2,075 crore
- Marico increased its stake in Satiya Nutraceuticals/Plix to 60% on a fully diluted basis
Why this matters
By lifting its stake in Plix owner Satiya Nutraceuticals to 60%, Marico gains majority control of a fast-growing nutraceutical platform and strengthens its position in premium wellness categories.
What to watch
- Quarterly volume growth versus price-led growth in the India business.
- Gross-margin and operating-margin trend, especially commentary on copra, edible oils, crude derivatives and packaging costs.
- Plix revenue growth, profitability, distribution expansion and evidence of post-acquisition integration.
- Advertising and promotion spending as a percentage of sales.
- International business growth trajectory and currency or country-specific headwinds.
- Management guidance on FY26 demand, rural consumption, premiumization and margin outlook.
- Use majority ownership to consolidate Plix's financials and expand its distribution through Marico's general-trade, modern-trade and e-commerce network.
- Increase cross-selling of health, nutrition and digital-first products alongside Saffola and other premium wellness offerings.
- Calibrate pricing and pack sizes in core categories to protect volume momentum while offsetting commodity inflation.
- Step up brand investment, product innovation and potential international-market launches for Plix.
- Prioritize margin recovery through procurement, supply-chain efficiencies and premium product mix.